Completed NA INTERVENTIONAL 2-arm NCT00487097

The Effect of Antioxidants on the Immune Response and Wound Healing in Critically Ill Patients

Effect of EPA, GLA and Antioxidants on the Immune Response - Cellular and Molecular Mechanisms of Wound Healing in Critically Ill Patients.

Sponsor: Rabin Medical Center

Conditions Intensive Care Pressure Sores

Interventions Eicosapentanoic acid, docosahexaenoic acid

Updated 5 times since 2017 Last updated: Feb 15, 2013 Started: Sep 30, 2007 Primary completion: May 31, 2010 Completion: May 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00487097, this NA trial focuses on Intensive Care and Pressure Sores and remains completed. Sponsored by Rabin Medical Center, it has been updated 5 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rabin Medical Center

Data source: Rabin Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Petah Tikva, Israel